Log in

NASDAQ:MGLN - Magellan Health Stock Price, Forecast & News

$73.56
-0.66 (-0.89 %)
(As of 01/28/2020 09:12 AM ET)
Today's Range
$72.40
Now: $73.56
$73.97
50-Day Range
$73.56
MA: $76.79
$78.49
52-Week Range
$57.79
Now: $73.56
$81.04
Volume112,270 shs
Average Volume117,640 shs
Market Capitalization$1.80 billion
P/E Ratio262.71
Dividend YieldN/A
Beta0.66
Magellan Health, Inc provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. Read More…

Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNASDAQ:MGLN
CUSIP55907920
Phone602-572-6050

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.31 billion
Cash Flow$7.98 per share
Book Value$52.99 per share

Profitability

Net Income$24.18 million

Miscellaneous

Employees10,500
Market Cap$1.80 billion
Next Earnings Date2/27/2020 (Estimated)
OptionableOptionable

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.


Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health Inc (NASDAQ:MGLN) issued its earnings results on Friday, November, 1st. The company reported $1.23 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.31 by $0.08. The firm earned $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Magellan Health had a net margin of 0.10% and a return on equity of 3.21%. The business's quarterly revenue was down 1.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.45 earnings per share. View Magellan Health's Earnings History.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health issued an update on its FY19 earnings guidance on Friday, November, 1st. The company provided earnings per share guidance of $3.35-4.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.96. The company issued revenue guidance of $7-7.2 billion, compared to the consensus revenue estimate of $7.14 billion.

What price target have analysts set for MGLN?

2 brokerages have issued 1-year price targets for Magellan Health's shares. Their forecasts range from $67.00 to $84.00. On average, they expect Magellan Health's stock price to reach $75.50 in the next twelve months. This suggests a possible upside of 2.6% from the stock's current price. View Analyst Price Targets for Magellan Health.

What is the consensus analysts' recommendation for Magellan Health?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health.

Has Magellan Health been receiving favorable news coverage?

Press coverage about MGLN stock has trended somewhat positive on Tuesday, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Magellan Health earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Magellan Health.

Are investors shorting Magellan Health?

Magellan Health saw a decline in short interest in January. As of January 15th, there was short interest totalling 625,700 shares, a decline of 13.4% from the December 31st total of 722,900 shares. Based on an average daily volume of 163,800 shares, the short-interest ratio is presently 3.8 days. Currently, 2.6% of the company's shares are sold short. View Magellan Health's Current Options Chain.

Who are some of Magellan Health's key competitors?

What other stocks do shareholders of Magellan Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer LP Unit (ET), Netflix (NFLX), Ford Motor (F), UnitedHealth Group (UNH), General Motors (GM), Kohl's (KSS), AT&T (T), Starbucks (SBUX), Boston Scientific (BSX) and ConocoPhillips (COP).

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:
  • Mr. Barry Morgan Smith, Chairman, CEO & CEO of Magellan Healthcare (Age 65)
  • Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 55)
  • Mr. Daniel Norman Gregoire, Gen. Counsel & Sec. (Age 63)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 38)
  • Ms. Renie Shapiro Silver, SVP - Corp. Fin.

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Smith Graham & Co. Investment Advisors LP (0.72%), New York State Teachers Retirement System (0.25%), California Public Employees Retirement System (0.24%), Nisa Investment Advisors LLC (0.09%), State of Alaska Department of Revenue (0.07%) and Arizona State Retirement System (0.06%). Company insiders that own Magellan Health stock include Barry M Smith, Daniel N Gregoire, Jeffrey N West and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

Which institutional investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including Arizona State Retirement System, Smith Graham & Co. Investment Advisors LP, Strs Ohio, CWM Advisors LLC, Louisiana State Employees Retirement System, State of Alaska Department of Revenue and Summit X LLC. View Insider Buying and Selling for Magellan Health.

Which institutional investors are buying Magellan Health stock?

MGLN stock was bought by a variety of institutional investors in the last quarter, including New York State Teachers Retirement System, Advisors Preferred LLC, California Public Employees Retirement System, Alpha Windward LLC and Nisa Investment Advisors LLC. View Insider Buying and Selling for Magellan Health.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $73.56.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $1.80 billion and generates $7.31 billion in revenue each year. The company earns $24.18 million in net income (profit) each year or $2.44 on an earnings per share basis. Magellan Health employs 10,500 workers across the globe.View Additional Information About Magellan Health.

What is Magellan Health's official website?

The official website for Magellan Health is http://www.magellanhealth.com/.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]


MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  345 (Vote Outperform)
Underperform Votes:  361 (Vote Underperform)
Total Votes:  706
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Featured Article: Green Investing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel